Comparative Study on the Effect of and Seeds on Anthropometric Measures in Nonalcoholic Fatty Liver Patients

Overview

Journal Int J Prev Med

Date 2016 Oct 21

PMID 27761216

Citations 4

Authors

Shahab-Aldin Akbarian

Sedigheh Asgary

Awat Feizi

Bijan Iraj

Gholamreza Askari

Affiliations

Soon will be listed here.

Abstract

Background: Due to the attribution of fatty liver with some chronic diseases such as obesity, finding a way to control obesity can be useful for the management of fatty liver. This study was performed to assess the effects of (PP) and (OB) on anthropometric measurements in people with hepatic steatosis.

Methods: All patients with nonalcoholic fatty liver disease (NAFLD) were enrolled in this four-arm parallel, randomized, and single blind trial. They randomly assigned into four groups receiving (1) OB 10 g/day; (2) PP 10 g/day; (3) mix of OB and PP 10 g/day; and (4) control group without placebo for 12 weeks. Anthropometric measurements were assessed during study baseline and after 12 weeks intervention. The data were analyzed using paired sample -test for within group and analysis of covariance for between groups.

Results: In within group analysis, weight and body mass index show a significant reduction after 12 weeks intervention. In addition, soft lean mass and lean body mass were decreased in PP and mixed of PP and OB groups significantly; another group (OB) shows the same result for mass body fat. Although in intervention groups, we see considerable reduction, between group changes did not demonstrate the same consequences.

Conclusions: The results of this study showed that administration of OB, PP, or mix of them for 12 weeks does not affect any of the anthropometric measures in NAFLD.

Citing Articles

Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease.

Ciobarca D, Catoi A, Gavrilas L, Banc R, Miere D, Filip L Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006091 PMC: 11859434. DOI: 10.3390/ph18020279.

The Potential of Lamiaceae Herbs for Mitigation of Overweight, Obesity, and Fatty Liver: Studies and Perspectives.

Diab F, Zbeeb H, Baldini F, Portincasa P, Khalil M, Vergani L Molecules. 2022; 27(15).

PMID: 35956991 PMC: 9370348. DOI: 10.3390/molecules27155043.

Evaluation of Biosafety, Antiobesity, and Endothelial Cells Proliferation Potential of Basil Seed Extract Loaded Organic Solid Lipid Nanoparticle.

Subash-Babu P, Al-Saran N, Alshammari G, Al-Harbi L, Hussain Alhussain M, Shamlan G Front Pharmacol. 2021; 12:722258.

PMID: 34671255 PMC: 8521050. DOI: 10.3389/fphar.2021.722258.

The Relationship between Prebiotic Supplementation and Anthropometric and Biochemical Parameters in Patients with NAFLD-A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Stachowska E, Portincasa P, Jamiol-Milc D, Maciejewska-Markiewicz D, Skonieczna-Zydecka K Nutrients. 2020; 12(11).

PMID: 33187278 PMC: 7698299. DOI: 10.3390/nu12113460.

Current Evidence to Propose Different Food Supplements for Weight Loss: A Comprehensive Review.

Watanabe M, Risi R, Masi D, Caputi A, Balena A, Rossini G Nutrients. 2020; 12(9).

PMID: 32962190 PMC: 7551574. DOI: 10.3390/nu12092873.

References

Nomura K, Yamanouchi T . The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease. J Nutr Biochem. 2011; 23(3):203-8. DOI: 10.1016/j.jnutbio.2011.09.006. View

Trumbo P, Schlicker S, Yates A, Poos M . Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J Am Diet Assoc. 2002; 102(11):1621-30. DOI: 10.1016/s0002-8223(02)90346-9. View

Levrat M, Favier M, Moundras C, Remesy C, Demigne C, Morand C . Role of dietary propionic acid and bile acid excretion in the hypocholesterolemic effects of oligosaccharides in rats. J Nutr. 1994; 124(4):531-8. DOI: 10.1093/jn/124.4.531. View

Gariani K, Philippe J, Jornayvaz F . Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside. Diabetes Metab. 2012; 39(1):16-26. DOI: 10.1016/j.diabet.2012.11.002. View

Firestone D, HORWITZ W . IUPAC gas chromatographic method for determination of fatty acid composition: collaborative study. J Assoc Off Anal Chem. 1979; 62(4):709-21. View

Pascale A, Pais R, Ratziu V . An overview of nonalcoholic steatohepatitis: past, present and future directions. J Gastrointestin Liver Dis. 2010; 19(4):415-23. View

Vinklarkova B, Chromy V, Sprongl L, Bittova M, Rikanova M, Ohnutkova I . The Kjeldahl method as a primary reference procedure for total protein in certified reference materials used in clinical chemistry. II. Selection of direct Kjeldahl analysis and its preliminary performance parameters. Crit Rev Anal Chem. 2015; 45(2):112-8. DOI: 10.1080/10408347.2014.892821. View

Wanders A, Mars M, Borgonjen-van den Berg K, de Graaf C, Feskens E . Satiety and energy intake after single and repeated exposure to gel-forming dietary fiber: post-ingestive effects. Int J Obes (Lond). 2013; 38(6):794-800. DOI: 10.1038/ijo.2013.176. View

Foroughi M, Maghsoudi Z, Ghiasvand R, Iraj B, Askari G . Effect of Vitamin D Supplementation on C-reactive Protein in Patients with Nonalcoholic Fatty Liver. Int J Prev Med. 2014; 5(8):969-75. PMC: 4258669. View

10.

Ziai S, Larijani B, Akhoondzadeh S, Fakhrzadeh H, Dastpak A, Bandarian F . Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients. J Ethnopharmacol. 2005; 102(2):202-7. DOI: 10.1016/j.jep.2005.06.042. View

11.

Vuksan V, Jenkins A, Rogovik A, Fairgrieve C, Jovanovski E, Leiter L . Viscosity rather than quantity of dietary fibre predicts cholesterol-lowering effect in healthy individuals. Br J Nutr. 2011; 106(9):1349-52. DOI: 10.1017/S0007114511001711. View

12.

Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S . Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol. 1997; 27(1):103-7. DOI: 10.1016/s0168-8278(97)80287-5. View

13.

Lee S, Park S . Radiologic evaluation of nonalcoholic fatty liver disease. World J Gastroenterol. 2014; 20(23):7392-402. PMC: 4064084. DOI: 10.3748/wjg.v20.i23.7392. View

14.

Fan J, Cao H . Role of diet and nutritional management in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2013; 28 Suppl 4:81-7. DOI: 10.1111/jgh.12244. View

15.

Asgharian A, Askari G, Esmailzade A, Feizi A, Mohammadi V . The Effect of Symbiotic Supplementation on Liver Enzymes, C-reactive Protein and Ultrasound Findings in Patients with Non-alcoholic Fatty Liver Disease: A Clinical Trial. Int J Prev Med. 2016; 7:59. PMC: 4809112. DOI: 10.4103/2008-7802.178533. View

16.

Milic S, Lulic D, Stimac D . Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol. 2014; 20(28):9330-7. PMC: 4110564. DOI: 10.3748/wjg.v20.i28.9330. View

17.

Anderson J, Gustafson N, Smith S, Mackey M . Cholesterol-lowering effects of psyllium-enriched cereal as an adjunct to a prudent diet in the treatment of mild to moderate hypercholesterolemia. Am J Clin Nutr. 1992; 56(1):93-8. DOI: 10.1093/ajcn/56.1.93. View

18.

Pal S, Khossousi A, Binns C, Dhaliwal S, Ellis V . The effect of a fibre supplement compared to a healthy diet on body composition, lipids, glucose, insulin and other metabolic syndrome risk factors in overweight and obese individuals. Br J Nutr. 2010; 105(1):90-100. DOI: 10.1017/S0007114510003132. View

19.

Pittler M, Ernst E . Guar gum for body weight reduction: meta-analysis of randomized trials. Am J Med. 2001; 110(9):724-30. DOI: 10.1016/s0002-9343(01)00702-1. View

20.

Pittler M, Ernst E . Dietary supplements for body-weight reduction: a systematic review. Am J Clin Nutr. 2004; 79(4):529-36. DOI: 10.1093/ajcn/79.4.529. View